-
Cy7 NHS ester: Practical Labeling and QC Guide
2026-09-15
Cy7 NHS ester (SKU A8109) is a sulfonated, water-soluble amino-group labeling reagent for preparing near-infrared conjugates of proteins, peptides, and related biomolecules. It is appropriate for near-infrared fluorescent imaging and some live-cell or in vivo workflows, but it should not be treated as a universal probe or stored as a prepared solution for extended periods.
-
Moesin as a Biomarker of Endothelial Injury in Sepsis
2026-09-14
The reference study identifies moesin as a circulating marker associated with endothelial injury and sepsis severity, while also linking moesin to Rock1/MLC and NF-κB signaling in endothelial cells. Its integrated clinical, animal, and in vitro design provides a useful framework for connecting biomarker performance with vascular-barrier mechanisms.
-
5X Protein Loading Buffer (Reducing) Guide
2026-09-14
5X Protein Loading Buffer (Reducing), SKU K1164, standardizes denaturing and reducing protein sample preparation before conventional SDS-PAGE electrophoresis. It is appropriate for protein molecular weight separation but should not be used when native structure, biological activity, or non-reducing disulfide patterns must be preserved.
-
Chloroquine Diphosphate: Autophagy Assay Guide
2026-09-13
Chloroquine diphosphate provides a water-soluble way to interrogate lysosomal flux, therapy sensitization, and endolysosomal signaling without introducing DMSO. This practical guide connects dose-finding and orthogonal autophagy readouts with the LAMP1/LAMP2 findings reported in Japanese encephalitis virus research.
-
Force Thresholds, Nrf2, and Root Resorption
2026-09-12
A March 2026 study identifies the Nrf2/Keap1/p62 antioxidant pathway as a force-sensitive molecular switch in orthodontically induced root resorption. Its graded compression and mouse tooth-movement experiments suggest that moderate loading preserves redox balance, whereas excessive force overwhelms antioxidant regulation and intensifies inflammation and osteoclastogenesis.
-
Beyond the Cap: ARCA for Translational mRNA
2026-09-12
Synthetic mRNA performance is determined by more than sequence and delivery. This thought-leadership article examines how Anti Reverse Cap Analog, 3´-O-Me-m7G(5')ppp(5')G, can strengthen translation-focused workflows, interprets targeted mRNA delivery evidence in ischemic stroke, and provides a practical framework for integrating cap chemistry into translational research.
-
SMPD4, Ceramide, and Primary Cilia Development
2026-09-11
A 2024 Development study combines mouse genetics with SMPD4-deficient human iPSC-derived neural cells to connect sphingomyelin metabolism with brain malformation and primary cilium integrity. Its ceramide-rescue experiments provide mechanistic evidence that SMPD4-dependent lipid production supports neural progenitor survival and cerebellar development.
-
METTL16–SENP3–LTF Axis in HCC Ferroptosis
2026-09-11
Wang et al. identify a METTL16–SENP3–LTF signaling axis that links m6A-dependent RNA regulation to iron handling and ferroptosis resistance in hepatocellular carcinoma. The study combines cellular, organoid, mouse-model, biochemical, and human-sample evidence, highlighting this pathway as a mechanistically supported target for ferroptosis sensitization.
-
Topotecan: From DNA Traps to Translational Assays
2026-09-10
Topotecan is a Topo I inhibitor whose activity depends on DNA replication, lactone-state chemistry, exposure schedule, and repair capacity. This assay-centered guide shows how to translate SKF104864 biology into more rigorous glioma, pediatric tumor, and cancer research workflows.
-
KU-60019: ATM Kinase Inhibitor Workflow
2026-09-10
KU-60019 is a selective ATM kinase inhibitor for linking DNA damage response inhibition to glioma radiosensitization, survival signaling, and migration assays. This workflow combines practical dosing guidance with mechanistic controls that help distinguish ATM-dependent effects from nonspecific cytotoxicity.
-
DEV VP26, Actin–Myosin II, and Viral Proliferation
2026-09-09
A 2025 study combined VP26 interactomics with genetic and pharmacological perturbation to identify the host actin–myosin II network as a determinant of duck enteritis virus proliferation. Its strongest mechanistic evidence implicates MYH9 and shows that disrupting actin assembly or myosin II activity lowers viral output, while also defining important limits for cross-system interpretation.
-
A-769662: Practical AMPK Activation Workflows
2026-09-09
A-769662 provides reversible chemical control of AMPK for metabolic, autophagy, and proteasome studies. This workflow-focused guide explains dose finding, orthogonal readouts, assay controls, and how to interpret AMPK-driven autophagy suppression without confusing pathway activation with cellular energy starvation.
-
DMH1: A Selective ALK2 Inhibitor for Organoids
2026-09-08
DMH1 enables controlled BMP-pathway perturbation in pancreatic ductal organoids and non-small cell lung cancer research. This guide connects selective ALK2 inhibition with practical dosing, phospho-Smad and Id-gene readouts, organoid optimization, and troubleshooting strategies.
-
Flubendazole: Autophagy Research Workflow
2026-09-08
Flubendazole provides a practical, DMSO-compatible starting point for autophagy modulation research in cancer and neurodegenerative disease models. This guide connects compound handling with flux-aware assays, metabolic controls, and troubleshooting strategies while separating product use from findings reported in liver-fibrosis research.
-
Forsythoside E: PKM2 Assay Workflow Guide
2026-09-07
Build a target-to-phenotype workflow around Forsythoside E, a PKM2-directed immunometabolic tool for macrophage studies. This guide connects direct binding, glycolytic remodeling, STAT3/NLRP3 signaling, and translational sepsis-induced liver injury research while emphasizing controls and troubleshooting.